Evotec SE ADR (EVO) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $1.60 (-4.19%), Market cap $1.09B, 52-week low–high $2.31 ~ $4.73.
Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just " Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, immunology, pain and inflammation, infectious, kidney, liver, respiratory, fibrotic and metabolic diseases, and rare diseases. It is also developingcentral nervous system (CNS) and cardiometabolic diseases; and animal and women health. The company has collaboration agreements with Mass General Brigham and Joslin Diabetes Center fo
Financial statements, price targets, institutional (13F) holdings and related news for Evotec SE ADR are updated in real time on BlackAll Trade.
Evotec SE ADR trades at $1.60 (-4.19%). Real-time quotes and charts are available on BlackAll Trade.
Evotec SE ADR has a market cap of about $1.09B.
Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and